AMALRIC Marianne
Onglets principaux
marianne.amalric@univ-amu.fr
Equipe(s) de recherche
Cognition et pathophysiologie des ganglions de la base
Publications
http://api.archives-ouvertes.fr/search/?&fq=authLastNameFirstName_s:%28%22Amalric+Marianne%22%29&fl=LastNameFirstName_s,title_s,en_title_s,publicationDateY_i,authjournalTitle_s,docid,label_s,en_label_s,docType_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,abstract_s,en_abstract_s
&sort=publicationDate_s+desc
- Kjeld Laursen, Milad Zamani, Yasser Rezaeiyan, Seyedsina Hosseini, Tanmay Mondal, et al.. An Ultrasonically-Powered System for 1.06 mm 3 Implantable Optogenetics and Drug Delivery Dust. IEEE Transactions on Circuits and Systems II: Express Briefs, 2023, 70 (10), pp.3937-3941. ⟨10.1109/TCSII.2023.3289028⟩. ⟨hal-04260453⟩
- Abdel-Mouttalib Ouagazzal, Sonia Di Bisceglie Caballero, Aurelia Ces, Martine Liberge, Frederic Ambroggi, et al.. N° de poster: P10.05 Globus Pallidus Contribution to Motor Behaviour in Normal and Parkinson's Disease States: Optogenetic Studies in murine models. 6th World Parkinson Congress 2023 (WPC 2023),, Jul 2023, Barcelona (SPAIN), Spain. ⟨hal-04234909⟩
- Sonia Di Bisceglie Caballero, Aurelia Ces, Martine Liberge, Frederic Ambroggi, Marianne Amalric, et al.. Optogenetic Globus Pallidus Stimulation Improves Motor Deficits in 6-Hydroxydopamine-Lesioned Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences, 2023, 24 (9), pp.7935. ⟨10.3390/ijms24097935⟩. ⟨hal-04234861⟩
- Sonia Di Bisceglie Caballero, Aurelia Ces, Martine Liberge, Frederic Ambroggi, Marianne Amalric, et al.. Optogenetic Globus Pallidus Stimulation Improves Motor Deficits in 6-Hydroxydopamine-Lesioned Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences, 2023, 24 (9), pp.7935. ⟨10.3390/ijms24097935⟩. ⟨hal-04296470⟩
- Juliette Lhost, Isabelle Watabe, Didier Louber, Abdel-Mouttalib Ouagazzal, Martine Liberge, et al.. Interplay Between Inhibitory Control and Behavioural Flexibility: Impact of Dorsomedial Striatal Dopamine Denervation in Mice. Neuroscience, 2021, 477, pp.25 - 39. ⟨10.1016/j.neuroscience.2021.09.026⟩. ⟨hal-03414568⟩
- Marianne Amalric, Tommy Pattij, Ioannis Sotiropoulos, Joana M Silva, Nuno Sousa, et al.. Where Dopaminergic and Cholinergic Systems Interact: A Gateway for Tuning Neurodegenerative Disorders. Frontiers in Behavioral Neuroscience, 2021, 15, ⟨10.3389/fnbeh.2021.661973⟩. ⟨hal-03414870⟩
- Alexis Haddjeri-Hopkins, Mónica Tapia, Jorge Ramirez-Franco, Fabien Tell, Béatrice Marqueze-Pouey, et al.. Refining the Identity and Role of Kv4 Channels in Mouse Substantia Nigra Dopaminergic Neurons. eNeuro, 2021, 8, pp.ENEURO.0207 - 21.2021. ⟨10.1523/eneuro.0207-21.2021⟩. ⟨hal-03414818⟩
- A. M. Ouagazzal, A. Ces, S. Di Bisceglie Caballero, Frédéric Ambroggi, Marianne Amalric. Effects of external globus pallidus photostimulation on motor behavior in normal and hemi-parkinsonian mice. XIIIth International Basal Ganglia Society (IBAGS) meeting, Apr 2019, Biarritz, France. ⟨hal-02556654⟩
- Samira Ztaou, Marianne Amalric. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson’s disease. Neurochemistry International, 2019. ⟨hal-02385017v2⟩
- Samira Ztaou, Juliette Lhost, Isabelle Watabe, Giulia Giulia Torromino, Marianne Amalric. Striatal cholinergic interneurons regulate cognitive and affective dysfunction in partially dopamine-depleted mice. European Journal of Neuroscience, 2018, 48 (9), pp.2988-3004. ⟨10.1111/ejn.14153⟩. ⟨hal-01974268⟩
- Paolo Gubellini, Liliya Iskhakova, Yoland Smith, Marianne Amalric. Metabotropic Glutamate Receptors and Parkinson’s Disease: Basic and Preclinical Neuroscience. mGLU Receptors, Springer International Publishing, pp.33-57, 2017, ⟨10.1007/978-3-319-56170-7_3⟩. ⟨hal-03016270⟩
- Christiane Mourre, Christine Manrique, Jeremy Camon, Sabrine Aidi-Knani, Thierry Deltheil, et al.. Changes in SK channel expression in the basal ganglia after partial nigrostriatal dopamine lesions in rats: Functional consequences. Neuropharmacology, 2017, 113, Part A, pp.519-532. ⟨10.1016/j.neuropharm.2016.11.003⟩. ⟨hal-01470385⟩
- Samira Ztaou, Nicolas Maurice, Jeremy Camon, Gaëlle Guiraudie-Capraz, Lydia Kerkerian-Le Goff, et al.. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease. Journal of Neuroscience, 2016, 36 (35), pp.9161-9172. ⟨10.1523/JNEUROSCI.0873-16.2016⟩. ⟨hal-01470425⟩
- Nicolas Maurice, Martine Liberge, Florence Jaouen, Samira Ztaou, Marwa Hanini, et al.. Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental Parkinsonism. Cell Reports, 2015, 13 (4), pp.657-666. ⟨10.1016/j.celrep.2015.09.034⟩. ⟨hal-02332256⟩
- Nicolas Maurice, Martine Liberge, Florence Jaouen, Samira Ztaou, Marwa Hanini, et al.. Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental Parkinsonism. Cell Reports, 2015, 13 (4), pp.657-666. ⟨10.1016/j.celrep.2015.09.034⟩. ⟨hal-02332092⟩
- Marianne Amalric. Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease. Current Opinion in Pharmacology, 2015, 20, pp.29-34. ⟨10.1016/j.coph.2014.11.001⟩. ⟨hal-01384021⟩
- Sabrine Aidi-Knani, Imed Regaya, Marianne Amalric, Christiane Mourre. Kv4 channel blockade reduces motor and neuropsychiatric symptoms in rodent models of Parkinson's disease. Behavioural Pharmacology, 2015, 26 (1-2, SI), pp.91-100. ⟨10.1097/FBP.0000000000000107⟩. ⟨hal-01384019⟩
- Nicolas Maurice, Thierry Deltheil, Christophe Melon, Bertrand Degos, Christiane Mourre, et al.. Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease. PLoS ONE, 2015, 10 (11), pp.e0142838. ⟨10.1371/journal.pone.0142838⟩. ⟨hal-01384032⟩
- Delphine Révy, Florence Jaouen, Pascal Salin, Christophe Melon, Dorian Chabbert, et al.. Cellular and Behavioral Outcomes of Dorsal Striatonigral Neuron Ablation: New Insights into Striatal Functions. Neuropsychopharmacology, 2014, 39 (11), pp.2662-2672. ⟨10.1038/npp.2014.121⟩. ⟨hal-03079407⟩
- Lin Chen, Thierry Deltheil, Nathalie Turle-Lorenzo, Martine Liberge, Corinne Rosier, et al.. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats. International Journal of Neuropsychopharmacology, 2014, 17 (8), pp.1295-1306. ⟨10.1017/S1461145714000236⟩. ⟨hal-01384068⟩
- Thierry Deltheil, Nathalie Turle-Lorenzo, Marianne Amalric. Effects of Group III mGluR Modulation in the Globus Pallidus of Parkinsonian Rats. Current Neuropharmacology, 2014, 12 (1), pp.13-14. ⟨hal-01384058⟩
- Francesca Manago, Sébastien Lopez, Alberto Oliverio, Marianne Amalric, Andrea Mele, et al.. Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice. Psychopharmacology, 2013, 226 (3), pp.541-550. ⟨10.1007/s00213-012-2925-4⟩. ⟨hal-01384085⟩
- Marianne Amalric, S. Lopez, C. Goudet, G. Fisone, G. Battaglia, et al.. Group III and subtype 4 metabotropic glutamate receptor agonists: Discovery and pathophysiological applications in Parkinson's disease. Neuropharmacology, 2013, 66 (SI), pp.53-64. ⟨10.1016/j.neuropharm.2012.05.026⟩. ⟨hal-01384098⟩
- S. Lopez, L. Jouve, N. Turle-Lorenzo, L. Kerkerian-Legoff, P. Salin, et al.. Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity.. Neurobiology of Disease, 2012, 46 (1), pp.69-77. ⟨10.1016/j.nbd.2011.12.045⟩. ⟨hal-00843334⟩
- Cyril Goudet, Bruno Vilar, Tiphanie Courtiol, Thierry Deltheil, Thomas Bessiron, et al.. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.. FASEB Journal, 2012, 26 (4), pp.1682-93. ⟨10.1096/fj.11-195941⟩. ⟨hal-01182946⟩
- Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, et al.. The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with L-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease. Journal of Pharmacology and Experimental Therapeutics, 2012, 340 (2), pp.404-421. ⟨10.1124/jpet.111.187443⟩. ⟨hal-01384126⟩
- A. Courtiere, J. Hardouin, Boris Burle, F. Vidal, N. Turle-Lorenzo, et al.. Dynamics of Executive Control and Motor Deficits in Parkinsonian Rats. Journal of Neuroscience, 2011, 31 (33), ⟨10.1523/JNEUROSCI.2550-11.2011⟩. ⟨hal-01308507⟩
- T. Deltheil, C. Rosier, N. Turle-Lorenzo, Lin Chen, C. Mourre, et al.. MODULATION OF POTASSIUM KCA2 CHANNELS AS AN ANTIPARKINSONIAN STRATEGY. Behavioural Pharmacology, 2011, 22 (S), pp.E45. ⟨hal-01384808⟩
- Roula Moussa, Bruno Poucet, Marianne Amalric, Francesca Sargolini. Contributions of dorsal striatal subregions to spatial alternation behavior. Learning and Memory, 2011, 18 (7), pp.444-451. ⟨10.1101/lm.2123811⟩. ⟨hal-01384807⟩
- Thierry Deltheil, Nathalie Turle-Lorenzo, Marianne Amalric. Orthosteric Group III mGlu Receptor Agonists for Parkinson's Disease Treatment: Symptomatic and Neurochemical Action on Pallidal Synaptic Transmission. Current Neuropharmacology, 2011, 9 (1), pp.14-15. ⟨hal-01384803⟩
